Last updated on November 2019

A Study to Evaluate the Safety Tolerability and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia

Brief description of study

This study is a randomized, double-blind, placebo-controlled study of the safety, tolerability, and efficacy of SAGE-217 compared to placebo in adult subjects with comorbid major depressive disorder and insomnia

Clinical Study Identifier: NCT03771664

Find a site near you

Start Over

Sage Investigational Site

Hollywood, FL United States
  Connect »